Preventive Care in Type 2 Diabetes Case Review | MDster You are offline Back online! [ MDster home ](/ "MDster home") Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Case Discussion ](https://mdster.com/blog?category=case-discussion) 4. Preventive Care in Type 2 Diabetes: A High-Risk Case Review [ Case Discussion ](https://mdster.com/blog?category=case-discussion) Preventive Care in Type 2 Diabetes: A High-Risk Case Review ============================================================= Prioritizing overdue screening, vaccination, and cardiovascular risk reduction during one preventive visit [ MDster Editorial Team ](https://mdster.com/about) · Aug 07, 2026 · 5 min read · 27 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) [ Internal Medicine ](https://mdster.com/blog?tag=internal-medicine) [ Type 2 Diabetes ](https://mdster.com/blog?tag=type-2-diabetes) [ Preventive Medicine ](https://mdster.com/blog?tag=preventive-medicine) [ Cardiovascular Risk ](https://mdster.com/blog?tag=cardiovascular-risk) [ Board Exam Review ](https://mdster.com/blog?tag=board-exam-review) [ Adult Immunization ](https://mdster.com/blog?tag=adult-immunization) ![Preventive Care in Type 2 Diabetes: A High-Risk Case Review](https://mdster.com/storage/blog/images/preventive-care-in-type-2-diabetes-a-high-risk-case-review.jpg) Share this article Share this post On this page 1. [ Preventive Screening That Cannot Wait ](#preventive-screening-that-cannot-wait) 2. [ Immunization Plan ](#immunization-plan) 3. [ Why Her Cardiovascular Risk Is High ](#why-her-cardiovascular-risk-is-high) 4. [ Lipids and Aspirin ](#lipids-and-aspirin) 5. [ Blood Pressure and Glycemic Management ](#blood-pressure-and-glycemic-management) 6. [ The Real Differential: Occult End-Organ Disease ](#the-real-differential-occult-end-organ-disease) 7. [ Medication Safety and Clinical Application ](#medication-safety-and-clinical-application) 8. [ Key Points for Board Exams ](#key-points-for-board-exams) 9. [ Conclusion ](#conclusion) 10. [ Frequently Asked Questions ](#blog-faqs) 11. [ References ](#references-heading) On this page 1. [ Preventive Screening That Cannot Wait ](#preventive-screening-that-cannot-wait) 2. [ Immunization Plan ](#immunization-plan) 3. [ Why Her Cardiovascular Risk Is High ](#why-her-cardiovascular-risk-is-high) 4. [ Lipids and Aspirin ](#lipids-and-aspirin) 5. [ Blood Pressure and Glycemic Management ](#blood-pressure-and-glycemic-management) 6. [ The Real Differential: Occult End-Organ Disease ](#the-real-differential-occult-end-organ-disease) 7. [ Medication Safety and Clinical Application ](#medication-safety-and-clinical-application) 8. [ Key Points for Board Exams ](#key-points-for-board-exams) 9. [ Conclusion ](#conclusion) 10. [ Frequently Asked Questions ](#blog-faqs) 11. [ References ](#references-heading) A well-appearing 62-year-old woman with diabetes, hypertension, obesity, dyslipidemia, and prior tobacco exposure is not a low-acuity visit. The immediate threat is cumulative, clinically silent cardiovascular, renal, and malignant disease—not an acute symptom requiring exclusion. Preventive Screening That Cannot Wait ------------------------------------- Four interventions are clearly due as of August 7, 2026: - **Colorectal cancer screening:** Her normal colonoscopy was 12 years ago; colonoscopy is recommended every 10 years for average-risk adults. If she declines, offer annual FIT, stool DNA-FIT every 1–3 years, or another accepted strategy. Any abnormal stool test requires colonoscopy. [\[1\]](#cite-1 "Reference [1]") - **Breast cancer screening:** Biennial mammography is recommended through age 74; her last study was two years ago. [\[2\]](#cite-2 "Reference [2]") - **Lung cancer screening:** Annual LDCT is indicated because she is aged 50–80, has a 20-pack-year history, and quit fewer than 15 years ago. [\[3\]](#cite-3 "Reference [3]") - **Hepatitis C screening:** Obtain anti-HCV testing once, followed by confirmatory HCV RNA testing if reactive. [\[4\]](#cite-4 "Reference [4]") Verify cervical screening history separately. Screening should not stop before age 65 unless adequate prior negative testing is documented. Immunization Plan ----------------- Several vaccines may be administered during the same visit: - Td or Tdap now because more than 10 years have elapsed since her last Tdap. - PCV20 or PCV21 once; alternatively, PCV15 followed by PPSV23 after one year. - Recombinant zoster vaccine as a two-dose series, separated by 2–6 months. - Hepatitis B vaccination after shared decision-making; diabetes is a relevant risk factor in adults aged 60 or older. - Review seasonal influenza and current COVID-19 vaccination status. [\[5\]](#cite-5 "Reference [5]") RSV vaccination is not automatically indicated from the supplied facts. At age 50–74, qualifying risks include diabetic end-organ disease, insulin or SGLT2 inhibitor treatment, severe obesity, and selected cardiopulmonary conditions. [\[6\]](#cite-6 "Reference [6]") Why Her Cardiovascular Risk Is High ----------------------------------- Diabetes, hypertension, obesity, dyslipidemia, age, and prior smoking amplify endothelial dysfunction, inflammation, and atherogenic lipoprotein exposure. Her absence of angina does not reduce the need for intensive risk-factor treatment. > **Clinical Pearl:** Routine ischemia screening is not recommended solely because an asymptomatic patient has diabetes. Treat the risk factors; investigate coronary disease when symptoms, vascular signs, or ECG abnormalities provide a clinical indication. [\[7\]](#cite-7 "Reference [7]") ### Lipids and Aspirin High-intensity statin therapy is indicated. Reasonable options include atorvastatin 40–80 mg or rosuvastatin 20–40 mg, targeting at least a 50% LDL reduction and an LDL below 70 mg/dL. Recheck lipids 4–12 weeks after initiation or dose adjustment. [\[7\]](#cite-7 "Reference [7]") Her triglyceride level of 160 mg/dL does not justify fibrate therapy. Lifestyle intervention and statin treatment remain the initial strategy. Do not routinely initiate aspirin. The USPSTF recommends against starting aspirin for primary prevention at age 60 or older, although ADA guidance permits individualized consideration in selected high-risk patients with low bleeding risk. For a board-style question, absence of established ASCVD generally favors no aspirin. [\[8\]](#cite-8 "Reference [8]") Blood Pressure and Glycemic Management -------------------------------------- Confirm her BP using proper technique and home readings. The treatment goal is below 130/80 mmHg; a systolic target below 120 mmHg may be considered in patients with high cardiovascular or kidney risk if safely tolerated. [\[7\]](#cite-7 "Reference [7]") If BP remains elevated, assess adherence and sodium intake, then titrate lisinopril or add a thiazide-like diuretic or dihydropyridine calcium-channel blocker. Check creatinine and potassium after renin–angiotensin system treatment changes. An HbA1c goal below 7% is appropriate because she has preserved function and no documented hypoglycemia. Continue metformin if renal function permits and discuss a GLP-1 receptor agonist with cardiovascular benefit, particularly given obesity and inadequate control. If CKD or heart failure is identified, an SGLT2 inhibitor becomes especially compelling. [\[9\]](#cite-9 "Reference [9]") The Real Differential: Occult End-Organ Disease ----------------------------------------------- Normal creatinine does not complete the diabetes assessment. The workup should include: - eGFR and spot UACR at least annually. - Dilated retinal examination if not current. - Comprehensive foot examination with monofilament testing and pulse assessment. - Orthostatic vitals when intensifying antihypertensive therapy. - Review for neuropathy, PAD, medication nonadherence, and secondary causes of dyslipidemia. [\[10\]](#cite-10 "Reference [10]") Medication Safety and Clinical Application ------------------------------------------ Address medication burden directly rather than allowing fear to prevent treatment: 1. Explain that statin-associated severe myopathy is rare; evaluate new bilateral proximal muscle symptoms rather than discontinuing reflexively. 2. Monitor dizziness, orthostasis, potassium, and renal function during BP intensification. 3. Minimize regimen complexity with once-daily dosing and combination tablets when appropriate. 4. Arrange short-interval follow-up for BP, tolerance, adherence, and laboratory response. Key Points for Board Exams -------------------------- - Annual FIT is the simplest alternative when colonoscopy is refused. - A normal serum creatinine does not exclude diabetic kidney disease; obtain UACR. - Diabetes plus additional ASCVD risk factors supports high-intensity statin therapy. - Routine aspirin initiation is inappropriate for most adults aged 60 or older without ASCVD. - Vaccination and cancer screening should be handled during the same visit as metabolic risk reduction. Conclusion ---------- The highest-value intervention is not choosing between screening and chronic disease management. It is completing both through prioritized, shared decisions and planned follow-up. Frequently Asked Questions ---------------------------- ### What should be offered if this patient refuses colonoscopy? Offer annual FIT as a practical alternative. Stool DNA-FIT every 1–3 years and CT colonography every five years are also accepted; any positive result requires colonoscopy. ### Should aspirin be started because she has diabetes? Not routinely. At age 62 without established ASCVD, USPSTF guidance recommends against initiation; ADA allows only individualized consideration after assessing cardiovascular and bleeding risks. ### Which pneumococcal vaccine regimen is preferred? A single PCV20 or PCV21 dose completes vaccination for a previously unvaccinated adult. PCV15 followed by PPSV23 after one year is an alternative. ### Is an HbA1c target below 7% too strict at age 62? No. It is appropriate when cognition, function, and life expectancy are preserved and treatment can be intensified without significant hypoglycemia or burden. References (11) ------------------- 1. 1. [ www.uspreventiveservicestaskforce.org/uspstf/document/ClinicalSummaryFinal/colorectal-cancer-screening ](https://www.uspreventiveservicestaskforce.org/uspstf/document/ClinicalSummaryFinal/colorectal-cancer-screening) [↩](#cite-ref-1-1 "Back to text") 2. 2. [ www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening?os=win ](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening?os=win) [↩](#cite-ref-2-1 "Back to text") 3. 3. [ USPSTF Lung Cancer Screening Recommendation ](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening) [↩](#cite-ref-3-1 "Back to text") 4. 4. [ www.uspreventiveservicestaskforce.org/uspstf/document/clinical-summary/hepatitis-c-screening ](https://www.uspreventiveservicestaskforce.org/uspstf/document/clinical-summary/hepatitis-c-screening) [↩](#cite-ref-4-1 "Back to text") 5. 5. [ CDC Adult Immunization Schedule Notes ](https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-notes.html) [↩](#cite-ref-5-1 "Back to text") 6. 6. [ www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/adults.html ](https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/adults.html) [↩](#cite-ref-6-1 "Back to text") 7. 7. [ ADA Standards of Care in Diabetes—2026: Cardiovascular Disease and Risk Management ](https://diabetesjournals.org/care/article/49/Supplement_1/S216/163933/10-Cardiovascular-Disease-and-Risk-Management) [↩](#cite-ref-7-1 "Back to text") 8. 8. [ USPSTF Aspirin for Primary Prevention Recommendation ](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medication) [↩](#cite-ref-8-1 "Back to text") 9. 9. [ ADA Standards of Care in Diabetes—2026: Glycemic Goals ](https://diabetesjournals.org/care/article/49/Supplement_1/S132/163927/6-Glycemic-Goals-Hypoglycemia-and-Hyperglycemic) [↩](#cite-ref-9-1 "Back to text") 10. 10. [ doi.org/10.2337/dc26-s011 ](https://doi.org/10.2337/dc26-s011) [↩](#cite-ref-10-1 "Back to text") 11. 11. [ USPSTF Colorectal Cancer Screening Recommendation ](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening) Next Turn reading into Internal Medicine performance ------------------------------------------------- - System‑based, exam‑style questions + explanations - Smarter review to reinforce weak topics - Build confidence with measurable progress [ Start practicing ](https://mdster.com/user/dashboard) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features\*. No commitment. Cancel anytime. \*AI SOE Examiner is limited to 10 cases monthly for Advanced & Bundle subscribers. Explore topics: [ # Internal Medicine ](https://mdster.com/blog?tag=internal-medicine) [ # Type 2 Diabetes ](https://mdster.com/blog?tag=type-2-diabetes) [ # Preventive Medicine ](https://mdster.com/blog?tag=preventive-medicine) [ # Cardiovascular Risk ](https://mdster.com/blog?tag=cardiovascular-risk) [ # Board Exam Review ](https://mdster.com/blog?tag=board-exam-review) [ # Adult Immunization ](https://mdster.com/blog?tag=adult-immunization) [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() More in Case Discussion ----------------------- [ See all ](https://mdster.com/blog?category=case-discussion) [### Pulmonary Aspiration During RSI: Small Bowel Obstruction Case 5 min read Aug 05, 2026 ](https://mdster.com/blog/pulmonary-aspiration-during-rsi-small-bowel-obstruction-case) [### Severe Infant Bronchiolitis and Secondary Superinfection: Clinical Discussion 5 min read Aug 03, 2026 ](https://mdster.com/blog/severe-infant-bronchiolitis-and-secondary-superinfection-clinical-discussion) [### Radiological Trauma Resuscitation: 'Dirty Bomb' Mass Casualty Management 6 min read Aug 01, 2026 ](https://mdster.com/blog/radiological-trauma-resuscitation-dirty-bomb-mass-casualty-management) Related Posts ------------- [ ![Pulmonary Aspiration During RSI: Small Bowel Obstruction Case](https://mdster.com/storage/blog/images/pulmonary-aspiration-during-rsi-small-bowel-obstruction-case.jpg) Case Discussion ### Pulmonary Aspiration During RSI: Small Bowel Obstruction Case An SOE-style case exploring resuscitation before emergency laparotomy, aspiration during rapid sequence induction, lung injury, and ICU management. 5 min read 0 comments ](https://mdster.com/blog/pulmonary-aspiration-during-rsi-small-bowel-obstruction-case) [ ![Sustainability and Spread in Care Pathways: Making Change Stick](https://mdster.com/storage/blog/images/sustainability-and-spread-in-care-pathways-making-change-stick.jpg) Medical Education ### Sustainability and Spread in Care Pathways: Making Change Stick Learn how to prevent care pathway decay and spread improvement safely through actionable feedback, workflow integration, role-based training, and local adaptation. 6 min read 0 comments ](https://mdster.com/blog/sustainability-and-spread-in-care-pathways-making-change-stick) [ ![Severe Infant Bronchiolitis and Secondary Superinfection: Clinical Discussion](https://mdster.com/storage/blog/images/severe-infant-bronchiolitis-and-secondary-superinfection-clinical-discussion.jpg) Case Discussion ### Severe Infant Bronchiolitis and Secondary Superinfection: Clinical Discussion A deep dive into managing severe infant bronchiolitis, evaluating fluid balance and SIADH risk, and identifying secondary bacterial pneumonia in pediatric emergency settings. 5 min read 0 comments ](https://mdster.com/blog/severe-infant-bronchiolitis-and-secondary-superinfection-clinical-discussion) [ ![Radiological Trauma Resuscitation: 'Dirty Bomb' Mass Casualty Management](https://mdster.com/storage/blog/images/radiological-trauma-resuscitation-dirty-bomb-mass-casualty-management.jpg) Case Discussion ### Radiological Trauma Resuscitation: 'Dirty Bomb' Mass Casualty Management A clinical guide to managing trauma and radiological contamination from dirty bomb exposures, focusing on resuscitation priorities, PPE, and combined injury triage. 6 min read 0 comments ](https://mdster.com/blog/radiological-trauma-resuscitation-dirty-bomb-mass-casualty-management) [ ![ADR Classification and Recognition: A Clinical Pharmacology Guide](https://mdster.com/storage/blog/images/adr-classification-and-recognition-a-clinical-pharmacology-guide.jpg) Medical Education ### ADR Classification and Recognition: A Clinical Pharmacology Guide Learn how to accurately classify and recognize adverse drug reactions (ADRs), differentiate drug allergy from intolerance, and navigate FDA MedWatch reporting. 4 min read 0 comments ](https://mdster.com/blog/adr-classification-and-recognition-a-clinical-pharmacology-guide) [ ![Managing Endocervical Dysplasia and Type 3 Transformation Zones](https://mdster.com/storage/blog/images/managing-endocervical-dysplasia-and-type-3-transformation-zones.jpg) Case Discussion ### Managing Endocervical Dysplasia and Type 3 Transformation Zones Explore the management of discordant cervical histology with ECC-proven CIN 3 in a Type 3 transformation zone, focusing on colposcopic criteria, HPV pathophysiology, and ASCCP surveillance. 5 min read 0 comments ](https://mdster.com/blog/managing-endocervical-dysplasia-and-type-3-transformation-zones) [ MDster home ](/ "MDster home") Master your medical exams with evidence-based learning. [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) Resources - [Blog](https://mdster.com/blog) - [Dashboard](https://mdster.com/user/dashboard) Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [ ](https://play.google.com/store/apps/details?id=com.mdster.app) [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept